U.S. Metals and Mining Stock News

NYSE:HHH
NYSE:HHHReal Estate

Do Diverging Moves Around Earnings Reveal a Turning Point in Howard Hughes' (HHH) Governance Story?

Recent filings show Concorde Financial Corp fully exited its position in Howard Hughes Holdings by selling 52,047 shares, while General Counsel Joseph Valane bought 1,260 shares shortly after the company posted fourth-quarter 2025 results with lower-than-expected EPS but higher-than-expected revenue of US$624.4 million. These opposing moves by an institutional investor and a senior insider come as Howard Hughes pursues a holding-company pivot, faces leverage concerns, and attracts growing...
NYSE:THC
NYSE:THCHealthcare

Tenet Healthcare (THC) Is Down 8.8% After Earnings Beat And Expanded Buybacks Has The Bull Case Changed?

Tenet Healthcare recently reported fourth-quarter 2025 results that exceeded consensus expectations, supported by stronger same-facility revenues, a favorable payer mix, higher patient acuity, and contributions from Ambulatory Care acquisitions, while also updating its 2026 revenue and earnings outlook and progress on its multi-billion-dollar share repurchase program. Alongside these results, the company’s capital allocation signals were underscored by US$1.40 billion of share repurchases...
NYSE:COUR
NYSE:COURConsumer Services

How Consumer365’s AI Course Endorsement Will Impact Coursera (COUR) Investors

Earlier in 2026, Consumer365 named Coursera as a leading platform in its Best AI Course Online coverage, spotlighting the company’s broad catalogue of AI programs created with universities and technology partners. The recognition emphasizes Coursera’s role in practical, certificate-based AI learning that blends academic content with hands-on projects and assessments, reinforcing its positioning in professional upskilling. We’ll now examine how Consumer365’s endorsement of Coursera’s AI...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

A Look At BioMarin Pharmaceutical (BMRN) Valuation After A Year Of Softer Share Price Momentum

BioMarin Pharmaceutical (BMRN) is back on investor watch after recent trading left the shares about 20% lower over the past year, despite annual revenue of US$3.2b and net income of US$348.9m. See our latest analysis for BioMarin Pharmaceutical. The recent 1 day share price return of 1.85% decline and 7 day share price return of 5.67% decline sit against a 90 day share price return of 10.93% and a 1 year total shareholder return of 19.73% decline, suggesting short term momentum has softened...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

What Strategic Education (STRA)'s Analyst Upgrades and Earnings Revisions Mean For Shareholders

In recent weeks, analysts have raised their earnings forecasts for Strategic Education and upgraded the stock to a Zacks Rank #1 (Strong Buy), signaling higher confidence in its expected financial performance. This broad-based improvement in earnings estimates suggests that analysts are reassessing the company’s underlying business trends rather than reacting to a single, one-off development. We’ll now examine how this stronger analyst earnings outlook may reshape Strategic Education’s...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Cognex’s AI-Focused Cost Cuts And New Buyback Might Change The Case For Investing In CGNX

Cognex recently reported a return to profitable growth, citing higher year-end factory automation spending, steady logistics demand, and authorizing an additional US$500 million share repurchase program alongside operational changes aimed at lowering costs. By pairing cost-cutting efforts with increased investment in AI-enabled machine vision, Cognex is signaling a focus on strengthening its competitive advantages rather than simply trimming expenses. Next, we’ll examine how the new US$500...
NYSE:FSS
NYSE:FSSMachinery

Federal Signal (FSS) Valuation Check As Strong Results Lift Revenue Growth And Financial Flexibility

Federal Signal (FSS) is on investors’ radar after recent results showed year over year revenue growth, higher profitability, and a stronger free cash flow margin, all of which change the picture for its financial flexibility. See our latest analysis for Federal Signal. The share price has pulled back recently, with a 30 day share price return of an 11.25% decline and a 90 day share price return of a 3.89% decline. However, the 1 year total shareholder return of 37.16% and 5 year total...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

EyePoint (EYPT) Is Down 14.2% After Weak Q4 Results And DURAVYU Optimism - What's Changed

EyePoint Pharmaceuticals reported fourth-quarter 2025 revenue of US$620,000 versus US$11.59 million a year earlier, with net loss widening to US$67.61 million and basic loss per share from continuing operations rising to US$0.81, while also granting long-term stock options and ending 2025 with cash reportedly sufficient to fund operations into late 2027. Despite weaker financial results, investor attention has shifted toward the CEO’s recent purchase of 1,500 shares, analyst optimism linked...
NYSE:GRMN
NYSE:GRMNConsumer Durables

The Bull Case For Garmin (GRMN) Could Change Following New High-End 360-Degree Marine Sonar Launch

Garmin recently launched a premium 360-degree scanning sonar system with the motorized Spy Pole, offering anglers 2D and 3D, 360-degree underwater views, advanced GPS-integrated positioning, and wireless controls, with bundles priced around US$2,999.98 to US$3,199.98 and standalone Spy Pole units at US$1,999.99 to US$2,199.99. This new sonar and Spy Pole setup deepens Garmin’s presence in high-end Marine electronics by combining detailed underwater imaging with integrated, independent...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Critical Metals Taps Trade Attorney To Tackle Tanbreez Execution Risks

Critical Metals (NasdaqGM:CRML) has appointed international trade attorney Chang Oh Turkmani to its Advisory Board. Turkmani brings experience in global trade, commodity markets, and infrastructure development to support the Tanbreez rare earth project. The company highlights her role in cross border negotiations and supply chain planning as it advances its flagship Greenland asset. For investors tracking rare earth exposure, Critical Metals, listed as NasdaqGM:CRML, is positioning its...
NYSE:DVA
NYSE:DVAHealthcare

DaVita Mixes Strong Value Signals With Distress Score And Insider Selling

DaVita (NYSE:DVA) is showing an unusual mix of signals, with a Strong Buy Quant Rating alongside distress-level Altman Z-Score readings. The company reports robust revenue growth and margin expansion while insiders have been selling shares in meaningful amounts. This combination of financial strength indicators and red flags has not been covered in recent discussions of DaVita. DaVita, a major provider of kidney care services, sits at the intersection of healthcare demand and reimbursement...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

Is It Time To Reassess QCR Holdings (QCRH) After Recent Share Price Weakness?

Wondering if QCR Holdings at around US$82.64 is offering value or asking too much at today's price? This breakdown will help you see what the current market is really pricing in. The stock has seen a 0.9% decline over the last 7 days and a 10.5% decline over the last 30 days, while returns sit at 0.6% year to date and 11.6% over the past year. This gives you a mixed set of signals to weigh. Recent news coverage has focused on QCR Holdings as a regional banking name that investors continue to...
NasdaqGS:EXPO
NasdaqGS:EXPOProfessional Services

Assessing Exponent (EXPO) Valuation After Recent Share Pullback And Mixed Growth Expectations

Investor snapshot on Exponent Exponent (EXPO) has drawn fresh attention after recent share performance, with the stock down around 10% over the past 3 months and 18% over the past year. This has prompted investors to reassess its valuation. See our latest analysis for Exponent. With the share price at US$66.71, Exponent’s recent moves show pressure building rather than momentum, with a 7 day share price return of 7.19% and a 1 year total shareholder return of 18.33% pointing to weaker...
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Payoneer ESOP Shelf Filing Raises Fresh Questions On Dilution And Growth

Payoneer Global (NasdaqGM:PAYO) has filed a shelf registration statement for a potential US$79 million offering tied to its Employee Stock Ownership Plan. The filing sets up the ability to issue or sell shares in connection with the ESOP over time, affecting how employee equity is managed. This move adds a fresh element to the Payoneer equity story beyond the recent focus on partnerships and valuation discussion. Payoneer operates a global payments and financial services platform that...
NYSE:RNR
NYSE:RNRInsurance

A Look At RenaissanceRe Holdings (RNR) Valuation After Recent Mixed Share Price Moves

RenaissanceRe Holdings stock snapshot after recent performance moves RenaissanceRe Holdings (RNR) has drawn fresh attention after mixed share price moves, with a slight gain over the past day, a small decline over the past week and month, and a stronger rise over the past 3 months. See our latest analysis for RenaissanceRe Holdings. Looking beyond the latest move around the US$294 share price, RenaissanceRe Holdings shows momentum that has cooled in the very short term but remains positive...
NYSE:GNL
NYSE:GNLREITs

Balance Sheet Deleveraging And Cost Controls Might Change The Case For Investing In Global Net Lease (GNL)

In recent meetings with Global Net Lease’s leadership, Citizens analyst Mitch Germain reaffirmed his view on the company after management outlined progress in cutting leverage from 8.5x at its peak to 6.7x by year-end 2025 through approximately US$3.40 billion of asset sales, alongside an updated capital allocation plan. The company also reported past fourth-quarter 2025 earnings per share of US$0.16, beating analyst expectations despite revenue falling short, indicating that cost controls...
NasdaqGS:VC
NasdaqGS:VCAuto Components

Is It Time To Reconsider Visteon (VC) After The Recent Share Price Pullback?

If you are wondering whether Visteon at around US$90 offers genuine value or only appears cheap on the surface, this breakdown will help you frame that question clearly. The stock is around US$90.06 after a 0.7% fall over 7 days, a 14.2% drop over 30 days and a 7.0% decline year to date. The 1 year return is 12.7%, and the 3 and 5 year returns are 42.3% and 25.8% lower respectively. These mixed returns have put the focus back on what investors are paying for Visteon's future. Recent coverage...
NYSE:HRI
NYSE:HRITrade Distributors

Herc Holdings (HRI) Is Down 9.6% After Soft 2026 Outlook Tempers Strong Q4 Growth - What's Changed

Herc Holdings recently reported fourth-quarter 2025 revenue of US$1.21 billion, up 27.1% year on year but below analyst expectations, and issued full-year revenue and EBITDA guidance that also came in weaker than the market had anticipated. The company is emphasizing integration of its June 2025 purchase of H&E, the largest acquisition in its industry, as a key lever for long-term value creation despite the softer outlook. We’ll now examine how Herc’s weaker-than-expected full-year guidance,...
NYSE:RRX
NYSE:RRXElectrical

Is Regal Rexnord’s (RRX) Extended CEO Timeline Reinforcing Stability or Signaling Strategic Crossroads?

Regal Rexnord recently updated investors on its CEO succession process, stating that current CEO Louis Pinkham will remain in place until June 30, 2026, or until a successor is appointed, while the board’s search committee advances its identification of several highly qualified candidates. This extended timeline and structured search process underscore the board’s emphasis on leadership continuity, an important consideration for a company executing complex integration, automation, and...
NYSE:TME
NYSE:TMEEntertainment

Tencent Music (TME) Is Up 9.9% After Earnings Beat And Dividend Launching – Has The Bull Case Changed?

Tencent Music Entertainment Group recently reported fourth-quarter and full-year 2025 results showing higher revenue and net income year-on-year, and announced an ordinary annual cash dividend of US$0.12 per share (US$0.24 per ADS), totaling about US$368.00 million, payable to shareholders of record as of April 2, 2026. The combination of stronger earnings and a defined cash return to shareholders through the declared dividend adds fresh context to Tencent Music’s existing investment...
NYSE:MPLX
NYSE:MPLXOil and Gas

MPLX Expands Gas And NGL Network While Cash Flow Story Evolves

MPLX (NYSE:MPLX) is increasing investment in natural gas and NGL infrastructure projects. The company is emphasizing fee-based, long term contracts that are less sensitive to oil price moves. Recent geopolitical tensions affecting oil markets have not directly affected MPLX's reported business performance. For investors watching MPLX at a share price of $58.1, the focus has shifted toward how its assets in natural gas and NGLs support the current business mix. The stock has returned 7.9%...
NYSE:WTS
NYSE:WTSMachinery

Did Record 2025 Results, Acquisitions and 2026 Outlook Just Shift Watts Water Technologies' (WTS) Investment Narrative?

Watts Water Technologies recently reported strong fourth-quarter and full-year 2025 results, highlighted by record financial metrics, contributions from the Haws, Superior Boiler and Saudi Cast acquisitions, and a quarterly dividend of US$0.52 per share paid on March 13, 2026. Alongside these results, management’s expectation of 8–12% sales expansion and operating margin improvement for 2026, combined with an analyst upgrade, has sharpened attention on how acquisitions and higher-margin...
NYSE:SR
NYSE:SRGas Utilities

Is Spire (SR) Still Attractive After Recent Share Price Gains?

Wondering if Spire's current share price still offers value, or if most of the opportunity is already priced in? This article breaks down what the numbers can and cannot tell you about that question. Spire recently closed at US$92.11, with returns of 0.3% over the past week and month, 10.7% year to date, and 25.7% over the last year, alongside 49.7% over three years and 57.5% over five years. Recent coverage around Spire has focused on its position within the gas utilities space and how...
NYSE:USPH
NYSE:USPHHealthcare

What U.S. Physical Therapy (USPH)'s New Performance-Tied Executive Incentives Mean For Shareholders

In early 2026, U.S. Physical Therapy introduced new executive incentive and bonus plans, including restricted stock units and annual bonuses linked to Adjusted EBITDA performance targets, while analysts commented on growth opportunities, Medicare rate trends, and acquisition activity. The shift toward performance-tied equity awards and bonuses offers a clearer view of how management incentives may influence capital allocation, growth priorities, and risk-taking across the business. We will...